Health minister Norihisa Tamura gave his final approval Friday for emergency use of two more COVID-19 vaccines — developed by Moderna and AstraZeneca, respectively — in hopes of giving the developed world’s slowest vaccine rollout a much-needed shot in the arm.
However, British-Swedish drugmaker AstraZeneca PLC’s shots will not initially be used while the government weighs whether to place age restrictions on the jabs following reports of very rare blood clots overseas.
Unable to view this article?
This could be due to a conflict with your ad-blocking or security software.
Please add japantimes.co.jp and piano.io to your list of allowed sites.
If this does not resolve the issue or you are unable to add the domains to your allowlist, please see out this support page.
We humbly apologize for the inconvenience.